Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice
2011
Shewanella secretes flavins that mediate extracellular electron transfer
2008 Standout
Effects of Dorzolamide Hydrochloride on Ocular Tissues
2004
Mass spectrometry‐based metabolomics
2006 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Metabolic Disposition and Pharmacokinetics of [14C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
2001
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Determination of indinavir, potassium sorbate, methylparaben, and propylparaben in aqueous pediatric suspensions
1999
Discovery of a regioselectivity switch in nitrating P450s guided by molecular dynamics simulations and Markov models
2016 StandoutNobel
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Ritonavir
1998
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
1999 Standout
Simultaneous development of six LC–MS–MS methods for the determination of multiple analytes in human plasma
2002
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
2006
Direct analysis of protein complexes using mass spectrometry
1999 Standout
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
Ocular Drug Delivery
2010 Standout
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
1999
Novel liquid chromatographic–tandem mass spectrometric methods using silica columns and aqueous–organic mobile phases for quantitative analysis of polar ionic analytes in biological fluids
2001
Liquid chromatography/tandem mass spectrometric bioanalysis using normal‐phase columns with aqueous/organic mobile phases – a novel approach of eliminating evaporation and reconstitution steps in 96‐well SPE
2002
Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1
1999
Validation of new methods
2006 Standout
Quantitative high‐throughput analysis of drugs in biological matrices by mass spectrometry
2003
Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography–tandem mass spectrometry method for the analysis of fluconazole in human plasma
2003
State of the art in hair analysis for detection of drug and alcohol abuse
2006 Standout
Disulfonimide‐Catalyzed Asymmetric Vinylogous and Bisvinylogous Mukaiyama Aldol Reactions
2010 StandoutNobel
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Development and validation of an improved liquid chromatography–mass spectrometry method for the determination of pemetrexed in human plasma
2009
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis
2002
Hydrophilic interaction chromatography
2006 Standout
A study of ion suppression effects in electrospray ionization from mobile phase additives and solid‐phase extracts
2003
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
High-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the analysis of antidiabetic drugs in aqueous environmental samples
2012
Safety assessment of esters of p-hydroxybenzoic acid (parabens)
2005 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Celecoxib Inhibits Interleukin-12 αβ and β2 Folding and Secretion by a Novel COX2-Independent Mechanism Involving Chaperones of the Endoplasmic Reticulum
2006
Cyclooxygenase-1-Coupled Prostaglandin Biosynthesis Constitutes an Essential Prerequisite for Skin Repair
2003
Analysis of anticancer drugs: A review
2011 Standout
Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats
2007 StandoutNobel
Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review
2017 Standout
Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis
2010
Development and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometric method for the analysis of paroxetine in human plasma
2003
Herb-Drug Interactions
2005 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotei—Quantitative Analysis Based on Information from the Literature
2003
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Selective determination of COXIBs in environmental water samples by mixed-mode solid phase extraction and liquid chromatography quadrupole time-of-flight mass spectrometry
2015
Down syndrome
2020 Standout
Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC–MS/MS)—Eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction
2005
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Genetik, Schmerz und Analgesie
2006
Hydrophilic interaction liquid chromatography (HILIC)—a powerful separation technique
2011 Standout
Overview of the Status and Global Strategy for Neonicotinoids
2010 Standout
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
Modern trends in solid phase extraction: New sorbent media
2015
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
In Vitro Anti-HIV-1 Synergy between Non-Nucleoside Reverse Transcriptase Inhibitors Nevirapine and Efavirenz
2001
Multianalyte Quantification of Vitamin B6 and B2 Species in the Nanomolar Range in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry
2005
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Relationship between Levels of Indinavir in Hair and Virologic Response to Highly Active Antiretroviral Therapy
2002
Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures
2004
Water Analysis: Emerging Contaminants and Current Issues
2014 Standout
Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid
2003
Comprehensive On-Line LC/LC/MS of Proteins
1997
Interventions for enhancing medication adherence
2008 Standout
Disulfonimid‐katalysierte asymmetrische vinyloge und bisvinyloge Mukaiyama‐Aldolreaktionen
2010 StandoutNobel
Species differences in N-glucuronidation.
1998
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Omeprazole
2010
Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and Indinavir
2001
Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery
2000
Interventions for enhancing medication adherence
2014 Standout
Do Fukui Function Maxima Relate to Sites of Metabolism? A Critical Case Study
2005
Comparing identified and statistically significant lipids and polar metabolites in 15‐year old serum and dried blood spot samples for longitudinal studies
2016
Novel developments and trends of analytical methods for drug analysis in biological and environmental samples by molecularly imprinted polymers
2017
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Application of Stable Isotope-Labeled Compounds in Metabolism and in Metabolism-Mediated Toxicity Studies
2008
The effect ofin vitrogastrointestinal digestion on the anti-inflammatory activity ofVitis viniferaL. leaves
2015
Polyphenols and Human Health: The Role of Bioavailability
2021 Standout
Screening Assay for Metal-Catalyzed Oxidation Inhibitors Using Liquid Chromatography−Mass Spectrometry with an N-Terminal β-Amyloid Peptide
2009
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population
2003
Personalized Therapy in Pain Management: Where Do We Stand?
2010
Works of Eric Woolf being referenced
Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
1996
Simultaneous investigation of indinavir nonlinear pharmacokinetics and bioavailability in healthy volunteers using stable isotope labeling technique: Study design and model‐independent data analysis
1999
Determination of MK-507, a novel topically effective carbonic anhydrase inhibitor, and its de-ethylated metabolite in human whole blood, plasma, and urine by high-performance liquid chromatography
1994
Determination of an in vivo metabolite of a human immunodeficiency virus protease inhibitor in human plasma by high-performance liquid chromatography with tandem mass spectrometry
1997
Simultaneous determination of omeprazole and 5′-hydroxyomeprazole in human plasma by liquid chromatography–tandem mass spectrometry
1998
Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching
1995
An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs
2016
Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry
2008
Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase‐2 Inhibitor, in Healthy Volunteers
2001
Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometry
2007
Optimization of multidimensional high-performance liquid chromatography for the determination of drugs in plasma by direct injection, micellar cleanup and photodiode array detection
1990
Determination of an investigational HIV integrase inhibitor in human plasma using high performance liquid chromatography with tandem mass spectrometric detection
2005
Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy Male Volunteers
2003
Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples
2007
Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance
2014
Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection
2000
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics
2001
High-throughput simultaneous determination of the HIV protease inhibitors indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC–MS/MS
2000
Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection
1998
Simultaneous Determination of Unlabeled and Deuterium-Labeled Indinavir in Human Plasma by High-Performance Liquid Chromatography with Tandem Mass Spectrometric Detection
1997
Single-Dose Pharmacokinetics of Indinavir and the Effect of Food
1998
Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity.
2005
Immunoaffinity Purification Using Anti-PEG Antibody Followed by Two-Dimensional Liquid Chromatography/Tandem Mass Spectrometry for the Quantification of a PEGylated Therapeutic Peptide in Human Plasma
2010